| pubmed-article:10717250 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10717250 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:10717250 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
| pubmed-article:10717250 | lifeskim:mentions | umls-concept:C0031809 | lld:lifeskim |
| pubmed-article:10717250 | lifeskim:mentions | umls-concept:C0035696 | lld:lifeskim |
| pubmed-article:10717250 | lifeskim:mentions | umls-concept:C0005516 | lld:lifeskim |
| pubmed-article:10717250 | lifeskim:mentions | umls-concept:C1513276 | lld:lifeskim |
| pubmed-article:10717250 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:10717250 | pubmed:dateCreated | 2000-5-11 | lld:pubmed |
| pubmed-article:10717250 | pubmed:abstractText | We assessed Stanniocalcin-1 (STC-1) mRNA expression in human normal tissues, various types of human cancer cell lines, and cancer tissues obtained during surgery. Using a reverse transcriptase-polymerase chain reaction (RT-PCR) assay developed to detect STC-1 mRNA, the transcripts were detected in 20 out of 21 cancer cell lines and in all tumor tissues from various types of cancer. Semi-quantitative analyses with multiplex RT-PCR showed that STC-1 mRNA tended to be enhanced in cancer tissues of hepatocellular carcinoma and colorectal cancer compared to background cancer-free tissues. Analysis of blood samples obtained from 11 patients with hepatocellular carcinoma before, after and during hepatectomy showed STC-1 mRNA expression in 8 out of 11 patients at least one time. Normal donor blood samples (n=31) were all-negative for STC-1 mRNA expression. Our results indicate that STC-1 mRNA might be a useful molecular marker for detection of tumor cells in blood from patients with various types of malignancies. | lld:pubmed |
| pubmed-article:10717250 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10717250 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10717250 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10717250 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10717250 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10717250 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10717250 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10717250 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10717250 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10717250 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:10717250 | pubmed:issn | 1019-6439 | lld:pubmed |
| pubmed-article:10717250 | pubmed:author | pubmed-author:NaganoHH | lld:pubmed |
| pubmed-article:10717250 | pubmed:author | pubmed-author:FujiwaraYY | lld:pubmed |
| pubmed-article:10717250 | pubmed:author | pubmed-author:SugitaYY | lld:pubmed |
| pubmed-article:10717250 | pubmed:author | pubmed-author:MiyamotoAA | lld:pubmed |
| pubmed-article:10717250 | pubmed:author | pubmed-author:SakonMM | lld:pubmed |
| pubmed-article:10717250 | pubmed:author | pubmed-author:MondenMM | lld:pubmed |
| pubmed-article:10717250 | pubmed:author | pubmed-author:ShiozakiKK | lld:pubmed |
| pubmed-article:10717250 | pubmed:author | pubmed-author:NakamoriSS | lld:pubmed |
| pubmed-article:10717250 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10717250 | pubmed:volume | 16 | lld:pubmed |
| pubmed-article:10717250 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10717250 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10717250 | pubmed:pagination | 799-804 | lld:pubmed |
| pubmed-article:10717250 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:10717250 | pubmed:meshHeading | pubmed-meshheading:10717250... | lld:pubmed |
| pubmed-article:10717250 | pubmed:meshHeading | pubmed-meshheading:10717250... | lld:pubmed |
| pubmed-article:10717250 | pubmed:meshHeading | pubmed-meshheading:10717250... | lld:pubmed |
| pubmed-article:10717250 | pubmed:meshHeading | pubmed-meshheading:10717250... | lld:pubmed |
| pubmed-article:10717250 | pubmed:meshHeading | pubmed-meshheading:10717250... | lld:pubmed |
| pubmed-article:10717250 | pubmed:meshHeading | pubmed-meshheading:10717250... | lld:pubmed |
| pubmed-article:10717250 | pubmed:meshHeading | pubmed-meshheading:10717250... | lld:pubmed |
| pubmed-article:10717250 | pubmed:meshHeading | pubmed-meshheading:10717250... | lld:pubmed |
| pubmed-article:10717250 | pubmed:meshHeading | pubmed-meshheading:10717250... | lld:pubmed |
| pubmed-article:10717250 | pubmed:meshHeading | pubmed-meshheading:10717250... | lld:pubmed |
| pubmed-article:10717250 | pubmed:meshHeading | pubmed-meshheading:10717250... | lld:pubmed |
| pubmed-article:10717250 | pubmed:meshHeading | pubmed-meshheading:10717250... | lld:pubmed |
| pubmed-article:10717250 | pubmed:meshHeading | pubmed-meshheading:10717250... | lld:pubmed |
| pubmed-article:10717250 | pubmed:meshHeading | pubmed-meshheading:10717250... | lld:pubmed |
| pubmed-article:10717250 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10717250 | pubmed:articleTitle | Assessment of Stanniocalcin-1 mRNA as a molecular marker for micrometastases of various human cancers. | lld:pubmed |
| pubmed-article:10717250 | pubmed:affiliation | Department of Surgery and Clinical Oncology, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan. | lld:pubmed |
| pubmed-article:10717250 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10717250 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10717250 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10717250 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10717250 | lld:pubmed |
